Atrial natriuretic peptide (ANP) is produced and secreted by atrial cells. We measured calf capillary filtration rate with prolonged venous-occlusion plethysmography of supine healthy male subjects during pharmacologic infusion of ANP (48 pmol/kg/min for 15 min; n = 6) and during placebo infusion (n = 7). Results during infusions were compared to prior control measurements. ANP infusion increased plasma [ANP] from 30 ---4 to 2,568 -+ 595 pmol/L. Systemic hemoconcentration occurred during ANP infusion: mean hematocrit and plasma colloid osmotic pressure increased 4.6 and 11.3%, respectively, relative to preinfusion baseline values (p < 0.05). Mean calf filtration, however, was significantly reduced from 0.15 to 0.08 ml/100 ml/min with ANP. Heart rate increased 20% with ANP infusion, whereas blood pressure was unchanged.
Summary: Atrial natriuretic peptide (ANP) is produced and secreted by atrial cells. We measured calf capillary filtration rate with prolonged venous-occlusion plethysmography of supine healthy male subjects during pharmacologic infusion of ANP (48 pmol/kg/min for 15 min; n = 6) and during placebo infusion (n = 7). Results during infusions were compared to prior control measurements. ANP infusion increased plasma [ANP] from 30 ---4 to 2,568 -+ 595 pmol/L. Systemic hemoconcentration occurred during ANP infusion: mean hematocrit and plasma colloid osmotic pressure increased 4.6 and 11.3%, respectively, relative to preinfusion baseline values (p < 0.05). Mean calf filtration, however, was significantly reduced from 0.15 to 0.08 ml/100 ml/min with ANP. Heart rate increased 20% with ANP infusion, whereas blood pressure was unchanged.
Calf conductance (blood flow/ arterial pressure) and venous compliance were unaffected by ANP infusion. Placebo infusion had no effect relative to prior baseline control measurements.
Although ANP induced systemic capillary filtration, in the calf, filtration was reduced with ANP. Therefore, pharmacologic ANP infusion enhances capillary filtration from the systemic circulation, perhaps at upper body or splanchnic sites or both, while having the opposite effect in the leg. Key Words: Extracellular fluid--Hemoconcentration--Capillary permeability--Capillary pressure.
Atrial natriuretic peptide (ANP) is a hormone produced and secreted by atrial myocytes on distention of the atria (1, 2 Values reported as mean -+ SEM, n = 6.
" p < 0.05.
Nuclear Medicine Division of Parkland Memorial Hospital, Dallas, Texas. Subjects were catheterized in an arm vein, after which they underwent the erythrocyte radiolabeling procedure.
Subjects were then instrumented while supine with their legs elevated -15°from horizontal (calves 15-20 cm above heart level, to facilitate emptying of leg veins) and knees slightly bent for comfort. Legs were supported with pillows and foam pads such that the calves were parallel to the gamma camera face and as close to it as possible without touching it. Subjects assumed this position -50 min before the beginning of control data collection and remained so through the study. After completion of the control venous occlusion/data collection period (see Calf Capillary Filtration Rate, Blood Volume, and Vascular Compliance for details), a 20-min period was allowed to ensure recovery from prolonged venous occlusion before beginning experimental data collection. The 9-min, 50 mm Hg venous occlusion for placebo or ANP data collection began 6 min after the onset of infusion, and infusion continued during venous occlusion (total infusion time = 15 min). Subjects were awake during data collection.
Statistical
analyses Raw data were coded by one investigator and subsequently analyzed by another without access to identifying information.
Paired t tests delineated effects of placebo infusion (n = 7) and ANP infusion (n = 6) relative to prior baseline control results for each subject group. Three subjects were in both placebo and ANP groups. Independent two-tailed t tests were employed to determine whether control data for the placebo and ANP subject groups were similar. In addition, correlation analysis determined significance of relationships between relevant variable pairs within protocol periods (16) . ABstat procedures performed all statistical tests, with significance set at 0.05 (Anderson-Bell, Inc.). Results are expressed as means -+ SEM. with ANP relative to preinfusion control values (Fig. !) . The single subject whose calf filtration increased with ANP had the lowest control value and was our oldest subject (47 years). Calf filtration related inversely with plasma colloid osmotic pressure during control data collection (R 2 = 0.846, Fig. 2 ), but this relationship became insignificant during ANP infusion (R 2 = 0.484, p = 0.125).
RESULTS

Intravenous
ANP infusion tended to increase calf blood flow per unit arterial pressure (conductance) and also tended to increase preocclusion calf-blood volume, yet mean arterial pressure was unaffected by ANP ( Atrial natriuretic peptide (prnol × _'1)
FIG. 3. Relationship between calf conductance and plasma
[ANP] during preinfusion control data collection. Three subjects were in both placebo and ANP groups; data points for those subjectsrepresent averagesof data from their two control periods, n = 10, R2 = 0.634, p = 0.006. Vol% equals milliliters per 100 ml tissue.
infusion groups were statistically similar. Placebo infusion had no effect on any variable relative to prior control measurements ( Table 2) .
DISCUSSION
Hematocrit and plasma colloid osmotic pressure findings confirm that a pharmacologic ANP stimulus produces hemoconcentration, in accordance with the literature (1,3,17 ).
Weidmann et al. (3)
pointed out that ANP-induced hemoconcentration occurs more quickly than if diuresis were responsible.
Our findings support their conclusion. A plasma volume reduction of-200 ml occurred during the 15-min ANP infusion we employed (estimated from hematocrit increase, assuming blood volume of -5 L; 5, 9) . To excrete this volume over such a short time would require a urine production rate of 13 ml/min, which is unlikely. We can conclude, therefore, that ANP enhanced fluid movement from plasma to interstitium in this study. Although we expected ANP to increase leg capillary filtration in accordance with the systemic hemoconcentration we observed, the opposite actually occurred: ANP infusion reduced leg filtration. This observation disagrees with prior studies in the human forearm, which reported either enhanced filtration (6, 7) or a tendency toward such (8) during ANP infusion. It is unlikely that differences in direction of response between this and earlier studies could be explained by differences in the peptides employed. Whereas one of the earlier studies did not report the ANP type used (6), the two other antecedent studies (7, 8) 
